The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model

被引:128
作者
Lim, Sang Yup
Kim, Yong Sook
Ahn, Youngkeun
Jeong, Myung Ho
Hong, Moon Hwa
Joo, Soo Yeon
Nam, Kwang Il
Cho, Jeong Gwan
Kang, Peter M.
Park, Jong Chun
机构
[1] Chonnam Natl Univ Hosp, Ctr Heart, Dept Cardiovasc Med, Kwangju 501757, South Korea
[2] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Kwangju, South Korea
[3] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA USA
[4] Harvard Univ, Sch Med, Boston, MA USA
关键词
mesenchymal stem cell; Akt; myocardial infarction; porcine;
D O I
10.1016/j.cardiores.2006.02.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study was designed to examine whether mesenchymal stem cells (MSCs) transduced with Akt enhance cardiac repair after transplantation into the ischemic porcine heart. Methods: MSCs isolated from porcine bone marrow and transduced with myr-Akt were transplanted into porcine hearts after experimental myocardial intarction (MI) using intracoronary injection [Group I, vehicle; Group II, MSCs; Group III, Akt-MSCs]. Myocardial single photon emission tomography (M-SPECT) was performed to assess myocardial function and the infarcted area. Pigs were also sacrificed for inummohistochemical characterization and histologic analysis. In addition, in vitro assays were performed to examine the resistance of Akt-MSCs to H2O2 stimulation. Results: Transplantation of MSCs into the ischemic porcine myocardium (Group II) increased the left ventricular ejection fraction (Delta LV EF; -6.3 +/- 15.1% versus 0.5 +/- 6.4%, P < 0.001) and decreased the Delta area of MI (6.8 +/- 5.6% versus -5.0 +/- 5.3%, P < 0.001) compared with the vehicle control (Group I). Transplantation of MSCs transduced with myr-Akt (Group III) resulted in further improvement in ALV EF (-6.3 +/- 15.1% versus 5.8 +/- 11.3%, P < 0.001) and in Delta area of MI (6.8 +/- 5.6% versus -17.0 +/- 7.6%, P < 0.001). Akt-MSCs were more resistant to apoptosis, and the levels of extracellular signal-regulated protein kinase (ERK) activation and vascular endothelial growth factor (VEGF) were higher in H2O2-stimulated Akt-MSCs. Conclusion: Cellular transplantation of Akt-MSCs further enhances the repair of injured myocardium. compared to MSC transplantation alone by increasing the number of viable MSCs after cellular transplantation. (c) 2006 European Society of Cardiology. Published by Elsevier B.V. All fights reserved.
引用
收藏
页码:530 / 542
页数:13
相关论文
共 36 条
[1]   Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow [J].
Campagnoli, C ;
Roberts, IAG ;
Kumar, S ;
Bennett, PR ;
Bellantuono, I ;
Fisk, NM .
BLOOD, 2001, 98 (08) :2396-2402
[2]   The Akt/PKB pathway: molecular target for cancer drug discovery [J].
Cheng, JQ ;
Lindsley, CW ;
Cheng, GZ ;
Yang, H ;
Nicosia, SV .
ONCOGENE, 2005, 24 (50) :7482-7492
[3]   New therapeutic strategies for heart failure: Left ventricular remodeling as a target [J].
Cohn, JN .
JOURNAL OF CARDIAC FAILURE, 2004, 10 (06) :S200-S201
[4]   Muscle regeneration by bone marrow derived myogenic progenitors [J].
Ferrari, G ;
Cusella-De Angelis, G ;
Coletta, M ;
Paolucci, E ;
Stornaiuolo, A ;
Cossu, G ;
Mavilio, F .
SCIENCE, 1998, 279 (5356) :1528-1530
[5]   The inflammatory response in myocardial infarction [J].
Frangogiannis, NG ;
Smith, CW ;
Entman, ML .
CARDIOVASCULAR RESEARCH, 2002, 53 (01) :31-47
[6]   Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells [J].
Gnecchi, M ;
He, HM ;
Liang, OD ;
Melo, LG ;
Morello, F ;
Mu, H ;
Noiseux, N ;
Zhang, LN ;
Pratt, RE ;
Ingwall, JS ;
Dzau, VJ .
NATURE MEDICINE, 2005, 11 (04) :367-368
[7]   Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease - Clinical trial and preliminary results [J].
Hamano, K ;
Nishida, M ;
Hirata, K ;
Mikamo, A ;
Li, TS ;
Harada, M ;
Miura, T ;
Matsuzaki, M ;
Esato, K .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (09) :845-847
[8]   Stem cell therapy for ischemic heart disease [J].
Hassink, RJ ;
Dowell, JD ;
de la Rivière, AB ;
Doevendans, PA ;
Field, LJ .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (10) :436-441
[9]  
JONES LM, 2002, THEORY PRACTICE HIST, P553
[10]   Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines [J].
Kamihata, H ;
Matsubara, H ;
Nishiue, T ;
Fujiyama, S ;
Tsutsumi, Y ;
Ozono, R ;
Masaki, H ;
Mori, Y ;
Iba, O ;
Tateishi, E ;
Kosaki, A ;
Shintani, S ;
Murohara, T ;
Imaizumi, T ;
Iwasaka, T .
CIRCULATION, 2001, 104 (09) :1046-1052